Showing results (101-110 of 322) with videos related to
Sort By:
Pageof 33
Oncotarget|January 12, 2017
Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09)Dok Hyun Yoon, Byeong Seok Sohn, Sung Yong Oh, et al.Leukemia Research|August 6, 2010
BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: a single center comparative analysis of efficacy and toxicityJeong Eun Kim, Dae Ho Lee, Changhoon Yoo, et al.American Journal of Clinical Pathology|November 20, 2012
Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphomaYoung Wha Koh, Hyo Jeong Kang, Chansik Park, et al.Onkologie|August 1, 2012
The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective studyByeong S Sohn, Dae H Lee, Eun K Kim, et al.Annals of Hematology|February 18, 2016
Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphomaJi Hyun Park, Dok Hyun Yoon, Shin Kim, et al.Scientific Reports|May 12, 2019
Efficacy of the novel CDK7 inhibitor QS1189 in mantle cell lymphomaYun Jung Choi, Dong Ha Kim, Dok Hyun Yoon, et al.Investigational New Drugs|September 17, 2009
Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trialByeong-Bae Park, Won Seog Kim, Hyeon Seok Eom, et al.Acta Haematologica|April 15, 2015
Autophagic Markers BECLIN 1 and LC3 are Associated with Prognosis of Multiple MyelomaGeunyoung Jung, Jin Roh, Hyangsin Lee, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 11, 2011
Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: registry analysis by the International Radioimmunotherapy NetworkKarin Hohloch, Angelika Bischof Delaloye, Christiane Windemuth-Kieselbach, et al.Hematological Oncology|September 17, 2014
The absolute lymphocyte to monocyte ratio is associated with poor prognosis in classical Hodgkin lymphoma patients younger than 60 years of ageYoung Wha Koh, Se Jin Jung, Dok Hyun Yoon, et al.Pageof 33